HKD 13.70 target is cited for CSPC Pharma stock

Published on 10/15/2026 at 22:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-half 2026 revenue reached RMB 18,594 million, up 40.1 percent. CSPC Pharma stock costs EUR 1.01 on October 15, 2026 at 10:17 p.m. CEST.

Analyst target and interim growth

On October 6, 2026, a reported Buy rating carried a HKD 13.70 target.
First-half 2026 revenue reached RMB 18,594 million, up 40.1 percent.
CSPC Pharma stock costs EUR 1.01 at Lang & Schwarz on October 15, 2026 at 10:17 p.m. CEST.
The ex-dividend date is October 20, 2026, with a 4.09 percent yield.

CSPC Pharma, HK1093012172, Illustration mit AI erstellt.

A reported Buy rating and HKD 13.70 target put a measurable valuation marker on CSPC Pharma stock. On October 6, 2026, The Globe and Mail reported that the latest rating was Buy with a HKD 13.70 target. Against the HKD 8.87 Hong Kong quote on October 15, 2026, that target stands 54.45 percent above the home-market price. CSPC Pharma stock was at EUR 1.01 at Lang & Schwarz on October 15, 2026 at 10:17 p.m. CEST.

Interim revenue sets the scale

The company reported RMB 18,594 million in revenue for the first half of 2026, an increase of 40.1 percent from the year-earlier period. Reported profit attributable to shareholders reached RMB 6,094 million, up 139.2 percent, while underlying profit rose 165.8 percent to RMB 6,164 million, according to CSPC Pharma.

Price sits inside the yearly range

The Hong Kong listing traded at HKD 8.87 on October 15, 2026 at 4:08 p.m. HKT, up 0.62 percent on the session. Its day range was HKD 8.72 to HKD 9.12, while the 52-week range was HKD 6.53 to HKD 10.96. The stock's year-to-date performance was 7.63 percent, and volume reached 64,024,514 shares against an average of 88,598,753.

Valuation and dates ahead

The company had a market capitalization of HKD 101.1 billion and a trailing P/E ratio of 11.62 on October 15, 2026. The indicated forward dividend yield was 4.09 percent, while Yahoo Finance listed October 20, 2026 as the ex-dividend date and November 19, 2026 as the earnings date.

Comparison with peers

CSPC Pharma (HKEX, HKD): P/E 11.62, market capitalization HKD 101.1 billion

Chugai Pharmaceutical (TSE, JPY): plus 3.21 percent, market capitalization JPY 10.3 trillion

GSK (LSE, GBP): plus 3.59 percent, market capitalization GBP 72.8 billion

European quote and investor calendar

The euro quotation provides a separate view for investors in Germany, while the HKD listing remains the home-market reference for valuation and range measures. The next dated items are the October 20, 2026 ex-dividend date and the November 19, 2026 earnings date.

CSPC Pharma was trading at EUR 1.01 at Lang & Schwarz on October 15, 2026 at 10:17 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of CSPC Pharma stock.